Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000935836-22-000622
Filing Date
2022-11-23
Accepted
2022-11-23 13:01:06
Documents
1

Document Format Files

Seq Description Document Type Size
1 tffpharm13g.htm SC 13G 29283
  Complete submission text file 0000935836-22-000622.txt   30476
Mailing Address 467 CPW NY NY 10025
Business Address
LYTTON LAURENCE W (Filed by) CIK: 0001105806 (see all company filings)

Type: SC 13G

Mailing Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746
Business Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746 737-802-1973
TFF Pharmaceuticals, Inc. (Subject) CIK: 0001733413 (see all company filings)

EIN.: 824344737 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91311 | Film No.: 221414998
SIC: 2834 Pharmaceutical Preparations